Key Takeaways
- Sector: Healthcare Healthtech & Medtech.
- Geography: India, Singapore.
Analysis
Quadria Capital has successfully closed its third healthcare-focused private equity fund, raising $1.07 billion—significantly exceeding its initial $800 million target. This milestone underscores the firm's commitment to advancing healthcare transformation across Asia, particularly in South and Southeast Asia.
Key Highlights:
- Fund Composition: The oversubscribed fund comprises over $954 million in primary commitments and $114 million in co-investment capital. An additional $300 million in co-investment capacity is anticipated during the investment phase, potentially bringing total deployable capital to approximately $1.3 billion.
- Strategic Focus on India: Approximately 60% of the fund is earmarked for deployment in India, reflecting the country's pivotal role in Quadria's investment strategy. The firm aims to address India's healthcare challenges by investing in areas such as single-specialty hospitals, diagnostic chains, medical devices, and pharmaceutical manufacturing, including APIs and CDMOs.
- Investor Confidence: Despite a challenging fundraising environment, Quadria attracted substantial commitments from existing investors—who increased their contributions by an average of 80%—as well as new capital from global institutions across North America, Europe, the GCC, and Asia. Notably, Indian banks, insurance companies, and family offices also participated, marking a significant rise in domestic investor involvement.
- Portfolio Development: Fund III is already nearly 40% deployed, with investments in companies like Aragen Life Sciences (a global CRDMO), NephroPlus (Asia's largest dialysis chain), and Maxivision (India's leading eye care chain). Quadria plans to build a portfolio of 10 high-impact healthcare companies through strategic majority and minority investments.
Leadership Perspective:
"Fund III's close, amid one of the most demanding fundraising climates in recent memory, is a powerful validation of our strategy and our mission," said Abrar Mir, Co-founder and Managing Partner of Quadria Capital. "It reflects deep global investor conviction in the transformational opportunity in Asian healthcare, where social impact and financial performance go hand in hand."
Dr. Amit Varma, Co-founder and Managing Partner, emphasized India's strategic importance: "Asia's healthcare sector is at a pivotal moment. We are entering a golden decade of transformation. Our investment philosophy centers on forging deep partnerships with India's healthcare visionaries as the 'partner of choice'."
About Quadria Capital:
Founded in 2012 by Abrar Mir and Dr. Amit Varma, Quadria Capital is an independent healthcare-focused private equity firm specializing in growth capital investments in small to mid-sized companies across South and Southeast Asia. With a robust investor base, proven leadership, and an impact-driven strategy, Quadria is poised to play a pivotal role in the next decade of healthcare transformation across Asia.